These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20051564)

  • 21. Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.
    Ziehr DR; Chen MH; Zhang D; Braccioforte MH; Moran BJ; Mahal BA; Hyatt AS; Basaria SS; Beard CJ; Beckman JA; Choueiri TK; D'Amico AV; Hoffman KE; Hu JC; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    BJU Int; 2015 Sep; 116(3):358-65. PubMed ID: 25124891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progression.
    Lamb DJ; Buttyan R
    J Urol; 2003 Apr; 169(4):1558. PubMed ID: 12629414
    [No Abstract]   [Full Text] [Related]  

  • 23. Implantable LHRH agonist for treatment of prostate cancer.
    Lajiness MJ
    Urol Nurs; 2006 Oct; 26(5):408, 414. PubMed ID: 17078331
    [No Abstract]   [Full Text] [Related]  

  • 24. New treatment for advanced prostate cancer.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101352
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal hormonal therapy for advanced prostatic carcinoma.
    Goktas S; Crawford ED
    Semin Oncol; 1999 Apr; 26(2):162-73. PubMed ID: 10597727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary hormonal manipulations in the treatment of castration refractory prostate cancer.
    Agarwal N; Vogelzang NJ
    BJU Int; 2011 Jul; 108(2):227-8. PubMed ID: 21410863
    [No Abstract]   [Full Text] [Related]  

  • 27. External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.
    Koontz BF; Lee WR
    Arch Esp Urol; 2011 Oct; 64(8):858-64. PubMed ID: 22052767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer drugs. Making sense of the options.
    Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
    [No Abstract]   [Full Text] [Related]  

  • 29. Early androgen deprivation for prostate cancer?
    Eisenberger MA; Walsh PC
    N Engl J Med; 1999 Dec; 341(24):1837-8. PubMed ID: 10588970
    [No Abstract]   [Full Text] [Related]  

  • 30. Encouraging results for Plenaxis in prostate cancer trial.
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):132-3. PubMed ID: 12722871
    [No Abstract]   [Full Text] [Related]  

  • 31. What should I know about Lupron Depot for treating prostate cancer?
    Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):7. PubMed ID: 22396997
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormonal therapy and radiation for prostate cancer: is it safe?
    Nanda A; D'Amico AV
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):979-81. PubMed ID: 20645684
    [No Abstract]   [Full Text] [Related]  

  • 33. [Early versus late hormonal treatment in advanced prostate cancer].
    Allepuz Losa C; Gil Martínez P; Gil Sanz MJ; Rioja Sanz LA
    Actas Urol Esp; 1999; 23(7):557-64. PubMed ID: 10488608
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: All-cause mortality in randomized trials of cancer screening.
    Parker C; Dearnaley D
    J Natl Cancer Inst; 2002 Jun; 94(11):861-2; author reply 865-6. PubMed ID: 12048276
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
    Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
    BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Information Concerning Endocrine Therapy and Adherence of Patients with Breast and Prostate Cancer.
    Linke B; Liebl P; Marten D; Stoll C; Jung B; Wuensch P; Huebner J
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):482-3. PubMed ID: 25869258
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiation plus hormone therapy reduces prostate cancer mortality.
    Cancer Discov; 2014 Apr; 4(4):OF1. PubMed ID: 24706660
    [No Abstract]   [Full Text] [Related]  

  • 38. [Zoladex (ICI) in the therapy of prostatic cancer patients].
    Popko AS; Dokshin KL
    Urol Nefrol (Mosk); 1996; (6):53-5. PubMed ID: 9036615
    [No Abstract]   [Full Text] [Related]  

  • 39. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 40. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
    Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
    N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.